Selective Serotonin Reuptake Inhibitor

Friday, November 22, 2024

Latest:

Pfizer withdraws all lots of OXBRYTA (voxelotor)
Wegovy lawsuit
Tepezza Lawsuit
The key factors that could contribute to the emergence of a new pandemic virus
FDA recalls Quinapril linked to Cancer

Faulty Drugs

Faulty Pharmaceutical Drugs Resources

December 14, 2011

SSRI and Potential Risk of Persistent Pulmonary Hypertension

Selective Serotonin Reuptake Inhibitor (SSRI) Antidepressants can increase Risk of Persistent Pulmonary Hypertension of the Newborn when used During Pregnancy.